Doxorubicin Effects Breast Cancer Proliferation via the NEAT1/miR-410-3p Axis
These data indicate that DOX may affect BC lines via NEAT1, and that miR410-3p is effective in this pathway. Our data confirm the contribution of NEAT1 and miR410-3p to DOX treatment. Therefore, they can be used as a biomarker for the diagnosis and treatment of BC.
Authors
- Zahra Azizi (ORCID: https://orcid.org/0000-0002-5456-6881)
- İbrahim Açıkbaş (ORCID: https://orcid.org/0000-0001-7483-1147)
- Cihangir Doğan (ORCID: https://orcid.org/0000-0001-9422-5996)
- Buket Er Urgancı (ORCID: https://orcid.org/0000-0002-5339-3835)
- Pervin Elvan Tokgün (ORCID: https://orcid.org/0000-0001-9025-4140)
Institutions
- Pamukkale University (TR)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-09-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.9.3495
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00